Business Segments Shenyang Xingqi Pharmaceutical Co.,Ltd.
Equities
300573
CNE100002DV1
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 71.08 CNY | +1.59% |
|
-2.38% | +1.12% |
| 01-05 | Xingqi Pharmaceutical Gets Nod for Supplementary Application for Atropine Sulfate Eye Drops | MT |
| 12-08 | Xingqi Pharmaceutical's 39 Products Stay in China's Insurance Drug Catalogue | MT |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
: Breakdown by Business Segment
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Manufacturing | 546M | 707M | 821M | 1.09B | 1.79B | |||||
Medical Service | 138M | 317M | 406M | 351M | 133M | |||||
Unallocated Other Operations | 5.46M | 3.81M | 23.2M | 27.86M | 19.49M | |||||
Medicine Manufacturing | - | - | - | - | - | |||||
Interest Expense | - | - | - | - | - | |||||
Income Tax Expense | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
Net Income | - | - | - | - | - |
Geographical Revenue Distribution History
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
China | 689M | 1.03B | 1.25B | 1.47B | 1.94B | |||||
Total Assets | 966M | 1.69B | 1.78B | 2.02B | 2.13B | |||||
Interest Expense | -5.94M | -5.99M | -937K | -1.44M | -5.71M | |||||
Income Tax Expense | 9.08M | 34.43M | 22.03M | 24.96M | 56.97M | |||||
D&A | 44.82M | 66.57M | 72.61M | 86.28M | 99.92M | |||||
CAPEX | -108M | -95.06M | -299M | -262M | -199M | |||||
Net Income | 87.98M | 195M | 212M | 240M | 338M | |||||
EBT | 103M | 244M | 234M | 265M | 395M | |||||
Operating Income | 106M | 248M | 250M | 277M | 425M |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition